Skip to main content
PMC home page
Gut logoLink to Gut
. 2000 Nov;47(Suppl 2):ii1–ii19. doi: 10.1136/gut.47.suppl_2.ii1

British Society of Gastroenterology guidelines for the management of the irritable bowel syndrome

J Jones, J Boorman, P Cann, A Forbes, J Gomborone, K Heaton, P Hungin, D Kumar, G Libby, R Spiller, N Read, D Silk, P Whorwell
PMCID: PMC1766762  PMID: 11053260

Full Text

The Full Text of this article is available as a PDF (237.0 KB).

Figure 1  .

Figure 1  

Open in a new tab

Stages in the evaluation of the irritable bowel syndrome (IBS).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aggarwal A., Cutts T. F., Abell T. L., Cardoso S., Familoni B., Bremer J., Karas J. Predominant symptoms in irritable bowel syndrome correlate with specific autonomic nervous system abnormalities. Gastroenterology. 1994 Apr;106(4):945–950. doi: 10.1016/0016-5085(94)90753-6. [DOI] [PubMed] [Google Scholar]
  2. Agréus L., Svärdsudd K., Nyrén O., Tibblin G. Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time. Gastroenterology. 1995 Sep;109(3):671–680. doi: 10.1016/0016-5085(95)90373-9. [DOI] [PubMed] [Google Scholar]
  3. Arffmann S., Andersen J. R., Hegnhøj J., Schaffalitzky de Muckadell O. B., Mogensen N. B., Krag E. The effect of coarse wheat bran in the irritable bowel syndrome. A double-blind cross-over study. Scand J Gastroenterol. 1985 Apr;20(3):295–298. doi: 10.3109/00365528509091653. [DOI] [PubMed] [Google Scholar]
  4. Bazzocchi G., Ellis J., Villanueva-Meyer J., Jing J., Reddy S. N., Mena I., Snape W. J., Jr Postprandial colonic transit and motor activity in chronic constipation. Gastroenterology. 1990 Mar;98(3):686–693. doi: 10.1016/0016-5085(90)90289-d. [DOI] [PubMed] [Google Scholar]
  5. Bengtsson U., Hanson L. A., Ahlstedt S. Survey of gastrointestinal reactions to foods in adults in relation to atopy, presence of mucus in the stools, swelling of joints and arthralgia in patients with gastrointestinal reactions to foods. Clin Exp Allergy. 1996 Dec;26(12):1387–1394. [PubMed] [Google Scholar]
  6. Bengtsson U., Nilsson-Balknäs U., Hanson L. A., Ahlstedt S. Double blind, placebo controlled food reactions do not correlate to IgE allergy in the diagnosis of staple food related gastrointestinal symptoms. Gut. 1996 Jul;39(1):130–135. doi: 10.1136/gut.39.1.130. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Bharucha A. E., Camilleri M., Ford M. J., O'Connor M. K., Hanson R. B., Thomforde G. M. Hyperventilation alters colonic motor and sensory function: effects and mechanisms in humans. Gastroenterology. 1996 Aug;111(2):368–377. doi: 10.1053/gast.1996.v111.pm8690201. [DOI] [PubMed] [Google Scholar]
  8. Blanchard E. B., Greene B., Scharff L., Schwarz-McMorris S. P. Relaxation training as a treatment for irritable bowel syndrome. Biofeedback Self Regul. 1993 Sep;18(3):125–132. doi: 10.1007/BF00999789. [DOI] [PubMed] [Google Scholar]
  9. Blanchard E. B., Schwarz S. P., Suls J. M., Gerardi M. A., Scharff L., Greene B., Taylor A. E., Berreman C., Malamood H. S. Two controlled evaluations of multicomponent psychological treatment of irritable bowel syndrome. Behav Res Ther. 1992 Mar;30(2):175–189. doi: 10.1016/0005-7967(92)90141-3. [DOI] [PubMed] [Google Scholar]
  10. Burns D. G. The risk of abdominal surgery in irritable bowel syndrome. S Afr Med J. 1986 Jul 19;70(2):91–91. [PubMed] [Google Scholar]
  11. Bytzer P., Stokholm M., Andersen I., Klitgaard N. A., Schaffalitzky de Muckadell O. B. Prevalence of surreptitious laxative abuse in patients with diarrhoea of uncertain origin: a cost benefit analysis of a screening procedure. Gut. 1989 Oct;30(10):1379–1384. doi: 10.1136/gut.30.10.1379. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. CHAUDHARY N. A., TRUELOVE S. C. The irritable colon syndrome. A study of the clinical features, predisposing causes, and prognosis in 130 cases. Q J Med. 1962 Jul;31:307–322. [PubMed] [Google Scholar]
  13. Camilleri M., Fealey R. D. Idiopathic autonomic denervation in eight patients presenting with functional gastrointestinal disease. A causal association? Dig Dis Sci. 1990 May;35(5):609–616. doi: 10.1007/BF01540409. [DOI] [PubMed] [Google Scholar]
  14. Cann P. A., Read N. W., Brown C., Hobson N., Holdsworth C. D. Irritable bowel syndrome: relationship of disorders in the transit of a single solid meal to symptom patterns. Gut. 1983 May;24(5):405–411. doi: 10.1136/gut.24.5.405. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Cann P. A., Read N. W., Cammack J., Childs H., Holden S., Kashman R., Longmore J., Nix S., Simms N., Swallow K. Psychological stress and the passage of a standard meal through the stomach and small intestine in man. Gut. 1983 Mar;24(3):236–240. doi: 10.1136/gut.24.3.236. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Cann P. A., Read N. W., Holdsworth C. D., Barends D. Role of loperamide and placebo in management of irritable bowel syndrome (IBS). Dig Dis Sci. 1984 Mar;29(3):239–247. doi: 10.1007/BF01296258. [DOI] [PubMed] [Google Scholar]
  17. Cann P. A., Read N. W., Holdsworth C. D. What is the benefit of coarse wheat bran in patients with irritable bowel syndrome? Gut. 1984 Feb;25(2):168–173. doi: 10.1136/gut.25.2.168. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Centonze V., Imbimbo B. P., Campanozzi F., Attolini E., Daniotti S., Albano O. Oral cimetropium bromide, a new antimuscarinic drug, for long-term treatment of irritable bowel syndrome. Am J Gastroenterol. 1988 Nov;83(11):1262–1266. [PubMed] [Google Scholar]
  19. Chiotakakou-Faliakou E., Kamm M. A., Roy A. J., Storrie J. B., Turner I. C. Biofeedback provides long-term benefit for patients with intractable, slow and normal transit constipation. Gut. 1998 Apr;42(4):517–521. doi: 10.1136/gut.42.4.517. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Cook I. J., van Eeden A., Collins S. M. Patients with irritable bowel syndrome have greater pain tolerance than normal subjects. Gastroenterology. 1987 Oct;93(4):727–733. doi: 10.1016/0016-5085(87)90434-3. [DOI] [PubMed] [Google Scholar]
  21. Corney R. H., Stanton R. Physical symptom severity, psychological and social dysfunction in a series of outpatients with irritable bowel syndrome. J Psychosom Res. 1990;34(5):483–491. doi: 10.1016/0022-3999(90)90022-v. [DOI] [PubMed] [Google Scholar]
  22. Creed F., Craig T., Farmer R. Functional abdominal pain, psychiatric illness, and life events. Gut. 1988 Feb;29(2):235–242. doi: 10.1136/gut.29.2.235. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Cullingford G. L., Coffey J. F., Carr-Locke D. L. Irritable bowel syndrome: can the patient's response to colonoscopy help with diagnosis? Digestion. 1992;52(3-4):209–213. doi: 10.1159/000200955. [DOI] [PubMed] [Google Scholar]
  24. Danivat D., Tankeyoon M., Sriratanaban A. Prevalence of irritable bowel syndrome in a non-Western population. Br Med J (Clin Res Ed) 1988 Jun 18;296(6638):1710–1710. doi: 10.1136/bmj.296.6638.1710. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Delvaux M., Denis P., Allemand H. Sexual abuse is more frequently reported by IBS patients than by patients with organic digestive diseases or controls. Results of a multicentre inquiry. French Club of Digestive Motility. Eur J Gastroenterol Hepatol. 1997 Apr;9(4):345–352. doi: 10.1097/00042737-199704000-00006. [DOI] [PubMed] [Google Scholar]
  26. Dew M. J., Evans B. K., Rhodes J. Peppermint oil for the irritable bowel syndrome: a multicentre trial. Br J Clin Pract. 1984 Nov-Dec;38(11-12):394–398. [PubMed] [Google Scholar]
  27. DiPalma J. A., Narvaez R. M. Prediction of lactose malabsorption in referral patients. Dig Dis Sci. 1988 Mar;33(3):303–307. doi: 10.1007/BF01535754. [DOI] [PubMed] [Google Scholar]
  28. Dobrilla G., Imbimbo B. P., Piazzi L., Bensi G. Longterm treatment of irritable bowel syndrome with cimetropium bromide: a double blind placebo controlled clinical trial. Gut. 1990 Mar;31(3):355–358. doi: 10.1136/gut.31.3.355. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Drossman D. A., Li Z., Andruzzi E., Temple R. D., Talley N. J., Thompson W. G., Whitehead W. E., Janssens J., Funch-Jensen P., Corazziari E. U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci. 1993 Sep;38(9):1569–1580. doi: 10.1007/BF01303162. [DOI] [PubMed] [Google Scholar]
  30. Drossman D. A., McKee D. C., Sandler R. S., Mitchell C. M., Cramer E. M., Lowman B. C., Burger A. L. Psychosocial factors in the irritable bowel syndrome. A multivariate study of patients and nonpatients with irritable bowel syndrome. Gastroenterology. 1988 Sep;95(3):701–708. doi: 10.1016/s0016-5085(88)80017-9. [DOI] [PubMed] [Google Scholar]
  31. Drossman D. A., Sandler R. S., McKee D. C., Lovitz A. J. Bowel patterns among subjects not seeking health care. Use of a questionnaire to identify a population with bowel dysfunction. Gastroenterology. 1982 Sep;83(3):529–534. [PubMed] [Google Scholar]
  32. Farah D. A., Calder I., Benson L., MacKenzie J. F. Specific food intolerance: its place as a cause of gastrointestinal symptoms. Gut. 1985 Feb;26(2):164–168. doi: 10.1136/gut.26.2.164. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Ford M. J., Miller P. M., Eastwood J., Eastwood M. A. Life events, psychiatric illness and the irritable bowel syndrome. Gut. 1987 Feb;28(2):160–165. doi: 10.1136/gut.28.2.160. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Francis C. Y., Duffy J. N., Whorwell P. J., Martin D. F. Does routine abdominal ultrasound enhance diagnostic accuracy in irritable bowel syndrome? Am J Gastroenterol. 1996 Jul;91(7):1348–1350. [PubMed] [Google Scholar]
  35. Francis C. Y., Whorwell P. J. Bran and irritable bowel syndrome: time for reappraisal. Lancet. 1994 Jul 2;344(8914):39–40. doi: 10.1016/s0140-6736(94)91055-3. [DOI] [PubMed] [Google Scholar]
  36. Frigerio G., Beretta A., Orsenigo G., Tadeo G., Imperiali G., Minoli G. Irritable bowel syndrome. Still far from a positive diagnosis. Dig Dis Sci. 1992 Feb;37(2):164–167. doi: 10.1007/BF01308166. [DOI] [PubMed] [Google Scholar]
  37. Fukudo S., Nomura T., Hongo M. Impact of corticotropin-releasing hormone on gastrointestinal motility and adrenocorticotropic hormone in normal controls and patients with irritable bowel syndrome. Gut. 1998 Jun;42(6):845–849. doi: 10.1136/gut.42.6.845. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Fukudo S., Nomura T., Muranaka M., Taguchi F. Brain-gut response to stress and cholinergic stimulation in irritable bowel syndrome. A preliminary study. J Clin Gastroenterol. 1993 Sep;17(2):133–141. doi: 10.1097/00004836-199309000-00009. [DOI] [PubMed] [Google Scholar]
  39. Gomborone J. E., Dewsnap P. A., Libby G. W., Farthing M. J. Selective affective biasing in recognition memory in the irritable bowel syndrome. Gut. 1993 Sep;34(9):1230–1233. doi: 10.1136/gut.34.9.1230. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Gomborone J., Dewsnap P., Libby G., Farthing M. Abnormal illness attitudes in patients with irritable bowel syndrome. J Psychosom Res. 1995 Feb;39(2):227–230. doi: 10.1016/0022-3999(94)00126-p. [DOI] [PubMed] [Google Scholar]
  41. Gorard D. A., Gomborone J. E., Libby G. W., Farthing M. J. Intestinal transit in anxiety and depression. Gut. 1996 Oct;39(4):551–555. doi: 10.1136/gut.39.4.551. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Gorard D. A., Libby G. W., Farthing M. J. 5-Hydroxytryptamine and human small intestinal motility: effect of inhibiting 5-hydroxytryptamine reuptake. Gut. 1994 Apr;35(4):496–500. doi: 10.1136/gut.35.4.496. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Gorard D. A., Libby G. W., Farthing M. J. Ambulatory small intestinal motility in 'diarrhoea' predominant irritable bowel syndrome. Gut. 1994 Feb;35(2):203–210. doi: 10.1136/gut.35.2.203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Greenbaum D. S. Preliminary report on antidepressant treatment of irritable bowel syndrome: comments on comparison with anxiolytic therapy. Psychopharmacol Bull. 1984 Fall;20(4):622–628. [PubMed] [Google Scholar]
  45. Greene B., Blanchard E. B. Cognitive therapy for irritable bowel syndrome. J Consult Clin Psychol. 1994 Jun;62(3):576–582. doi: 10.1037//0022-006x.62.3.576. [DOI] [PubMed] [Google Scholar]
  46. Greenson J. K., Stern R. A., Carpenter S. L., Barnett J. L. The clinical significance of focal active colitis. Hum Pathol. 1997 Jun;28(6):729–733. doi: 10.1016/s0046-8177(97)90183-0. [DOI] [PubMed] [Google Scholar]
  47. Gudmand-Höyer E., Riis P., Wulff H. R. The significance of lactose malabsorption in the irritable colon syndrome. Scand J Gastroenterol. 1973;8(3):273–278. [PubMed] [Google Scholar]
  48. Guthrie E., Creed F., Dawson D., Tomenson B. A controlled trial of psychological treatment for the irritable bowel syndrome. Gastroenterology. 1991 Feb;100(2):450–457. doi: 10.1016/0016-5085(91)90215-7. [DOI] [PubMed] [Google Scholar]
  49. Gwee K. A., Graham J. C., McKendrick M. W., Collins S. M., Marshall J. S., Walters S. J., Read N. W. Psychometric scores and persistence of irritable bowel after infectious diarrhoea. Lancet. 1996 Jan 20;347(8995):150–153. doi: 10.1016/s0140-6736(96)90341-4. [DOI] [PubMed] [Google Scholar]
  50. Hahn B. A., Kirchdoerfer L. J., Fullerton S., Mayer E. Patient-perceived severity of irritable bowel syndrome in relation to symptoms, health resource utilization and quality of life. Aliment Pharmacol Ther. 1997 Jun;11(3):553–559. doi: 10.1046/j.1365-2036.1997.00160.x. [DOI] [PubMed] [Google Scholar]
  51. Harvey R. F., Hinton R. A., Gunary R. M., Barry R. E. Individual and group hypnotherapy in treatment of refractory irritable bowel syndrome. Lancet. 1989 Feb 25;1(8635):424–425. doi: 10.1016/s0140-6736(89)90013-5. [DOI] [PubMed] [Google Scholar]
  52. Harvey R. F., Mauad E. C., Brown A. M. Prognosis in the irritable bowel syndrome: a 5-year prospective study. Lancet. 1987 Apr 25;1(8539):963–965. doi: 10.1016/s0140-6736(87)90304-7. [DOI] [PubMed] [Google Scholar]
  53. Heaton K. W., Ghosh S., Braddon F. E. How bad are the symptoms and bowel dysfunction of patients with the irritable bowel syndrome? A prospective, controlled study with emphasis on stool form. Gut. 1991 Jan;32(1):73–79. doi: 10.1136/gut.32.1.73. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Heaton K. W., O'Donnell L. J., Braddon F. E., Mountford R. A., Hughes A. O., Cripps P. J. Symptoms of irritable bowel syndrome in a British urban community: consulters and nonconsulters. Gastroenterology. 1992 Jun;102(6):1962–1967. doi: 10.1016/0016-5085(92)90320-x. [DOI] [PubMed] [Google Scholar]
  55. Heaton K. W., Radvan J., Cripps H., Mountford R. A., Braddon F. E., Hughes A. O. Defecation frequency and timing, and stool form in the general population: a prospective study. Gut. 1992 Jun;33(6):818–824. doi: 10.1136/gut.33.6.818. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Heitkemper M., Burr R. L., Jarrett M., Hertig V., Lustyk M. K., Bond E. F. Evidence for autonomic nervous system imbalance in women with irritable bowel syndrome. Dig Dis Sci. 1998 Sep;43(9):2093–2098. doi: 10.1023/a:1018871617483. [DOI] [PubMed] [Google Scholar]
  57. Hotopf M., Carr S., Mayou R., Wadsworth M., Wessely S. Why do children have chronic abdominal pain, and what happens to them when they grow up? Population based cohort study. BMJ. 1998 Apr 18;316(7139):1196–1200. doi: 10.1136/bmj.316.7139.1196. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Hovdenak N. Loperamide treatment of the irritable bowel syndrome. Scand J Gastroenterol Suppl. 1987;130:81–84. doi: 10.3109/00365528709091004. [DOI] [PubMed] [Google Scholar]
  59. Isgar B., Harman M., Kaye M. D., Whorwell P. J. Symptoms of irritable bowel syndrome in ulcerative colitis in remission. Gut. 1983 Mar;24(3):190–192. doi: 10.1136/gut.24.3.190. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Jones R., Lydeard S. Irritable bowel syndrome in the general population. BMJ. 1992 Jan 11;304(6819):87–90. doi: 10.1136/bmj.304.6819.87. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Jones V. A., McLaughlan P., Shorthouse M., Workman E., Hunter J. O. Food intolerance: a major factor in the pathogenesis of irritable bowel syndrome. Lancet. 1982 Nov 20;2(8308):1115–1117. doi: 10.1016/s0140-6736(82)92782-9. [DOI] [PubMed] [Google Scholar]
  62. Kay L., Jørgensen T., Jensen K. H. The epidemiology of irritable bowel syndrome in a random population: prevalence, incidence, natural history and risk factors. J Intern Med. 1994 Jul;236(1):23–30. doi: 10.1111/j.1365-2796.1994.tb01115.x. [DOI] [PubMed] [Google Scholar]
  63. Kellow J. E., Phillips S. F. Altered small bowel motility in irritable bowel syndrome is correlated with symptoms. Gastroenterology. 1987 Jun;92(6):1885–1893. doi: 10.1016/0016-5085(87)90620-2. [DOI] [PubMed] [Google Scholar]
  64. Kellow J. E., Phillips S. F., Miller L. J., Zinsmeister A. R. Dysmotility of the small intestine in irritable bowel syndrome. Gut. 1988 Sep;29(9):1236–1243. doi: 10.1136/gut.29.9.1236. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. King T. S., Elia M., Hunter J. O. Abnormal colonic fermentation in irritable bowel syndrome. Lancet. 1998 Oct 10;352(9135):1187–1189. doi: 10.1016/s0140-6736(98)02146-1. [DOI] [PubMed] [Google Scholar]
  66. Klein K. B. Controlled treatment trials in the irritable bowel syndrome: a critique. Gastroenterology. 1988 Jul;95(1):232–241. doi: 10.1016/0016-5085(88)90319-8. [DOI] [PubMed] [Google Scholar]
  67. Kruis W., Thieme C., Weinzierl M., Schüssler P., Holl J., Paulus W. A diagnostic score for the irritable bowel syndrome. Its value in the exclusion of organic disease. Gastroenterology. 1984 Jul;87(1):1–7. [PubMed] [Google Scholar]
  68. Kruis W., Weinzierl M., Schüssler P., Holl J. Comparison of the therapeutic effect of wheat bran, mebeverine and placebo in patients with the irritable bowel syndrome. Digestion. 1986;34(3):196–201. doi: 10.1159/000199329. [DOI] [PubMed] [Google Scholar]
  69. Kumar A., Kumar N., Vij J. C., Sarin S. K., Anand B. S. Optimum dosage of ispaghula husk in patients with irritable bowel syndrome: correlation of symptom relief with whole gut transit time and stool weight. Gut. 1987 Feb;28(2):150–155. doi: 10.1136/gut.28.2.150. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Latimer P., Sarna S., Campbell D., Latimer M., Waterfall W., Daniel E. E. Colonic motor and myoelectrical activity: a comparative study of normal subjects, psychoneurotic patients, and patients with irritable bowel syndrome. Gastroenterology. 1981 May;80(5 Pt 1):893–901. [PubMed] [Google Scholar]
  71. Lee C. T., Chuang T. Y., Lu C. L., Chen C. Y., Chang F. Y., Lee S. D. Abnormal vagal cholinergic function and psychological behaviors in irritable bowel syndrome patients: a hospital-based Oriental study. Dig Dis Sci. 1998 Aug;43(8):1794–1799. doi: 10.1023/a:1018848122993. [DOI] [PubMed] [Google Scholar]
  72. Lembo T., Fullerton S., Diehl D., Raeen H., Munakata J., Naliboff B., Mayer E. A. Symptom duration in patients with irritable bowel syndrome. Am J Gastroenterol. 1996 May;91(5):898–905. [PubMed] [Google Scholar]
  73. Lenz H. J., Raedler A., Greten H., Vale W. W., Rivier J. E. Stress-induced gastrointestinal secretory and motor responses in rats are mediated by endogenous corticotropin-releasing factor. Gastroenterology. 1988 Dec;95(6):1510–1517. doi: 10.1016/s0016-5085(88)80070-2. [DOI] [PubMed] [Google Scholar]
  74. Leri O., Tubili S., De Rosa F. G., Addessi M. A., Scopelliti G., Lucenti W., De Luca D. Management of diarrhoeic type of irritable bowel syndrome with exclusion diet and disodium cromoglycate. Inflammopharmacology. 1997;5(2):153–158. doi: 10.1007/s10787-997-0024-7. [DOI] [PubMed] [Google Scholar]
  75. Lessof M. H., Wraith D. G., Merrett T. G., Merrett J., Buisseret P. D. Food allergy and intolerance in 100 patients---local and systemic effects. Q J Med. 1980;49(195):259–271. [PubMed] [Google Scholar]
  76. Loening-Baucke V. Biofeedback training in children with functional constipation. A critical review. Dig Dis Sci. 1996 Jan;41(1):65–71. doi: 10.1007/BF02208585. [DOI] [PubMed] [Google Scholar]
  77. Longstreth G. F., Wolde-Tsadik G. Irritable bowel-type symptoms in HMO examinees. Prevalence, demographics, and clinical correlates. Dig Dis Sci. 1993 Sep;38(9):1581–1589. doi: 10.1007/BF01303163. [DOI] [PubMed] [Google Scholar]
  78. Luboinski J., Beaugerie L., Lamy P., Cosnes J., Gendre J. P., Le Quintrec Y. Les diarrhées fonctionnelles ne sont pas, pour la plupart, des formes cliniques mineures de colite lymphocytaire ou collagène. Gastroenterol Clin Biol. 1996;20(10):838–843. [PubMed] [Google Scholar]
  79. Lucey M. R., Clark M. L., Lowndes J., Dawson A. M. Is bran efficacious in irritable bowel syndrome? A double blind placebo controlled crossover study. Gut. 1987 Feb;28(2):221–225. doi: 10.1136/gut.28.2.221. [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. Lucock M. P., Morley S., White C., Peake M. D. Responses of consecutive patients to reassurance after gastroscopy: results of self administered questionnaire survey. BMJ. 1997 Sep 6;315(7108):572–575. doi: 10.1136/bmj.315.7108.572. [DOI] [PMC free article] [PubMed] [Google Scholar]
  81. Luman W., Williams A. J., Merrick M. V., Eastwood M. A. Idiopathic bile acid malabsorption: long-term outcome. Eur J Gastroenterol Hepatol. 1995 Jul;7(7):641–645. [PubMed] [Google Scholar]
  82. MacIntosh D. G., Thompson W. G., Patel D. G., Barr R., Guindi M. Is rectal biopsy necessary in irritable bowel syndrome? Am J Gastroenterol. 1992 Oct;87(10):1407–1409. [PubMed] [Google Scholar]
  83. MacQueen G., Marshall J., Perdue M., Siegel S., Bienenstock J. Pavlovian conditioning of rat mucosal mast cells to secrete rat mast cell protease II. Science. 1989 Jan 6;243(4887):83–85. doi: 10.1126/science.2911721. [DOI] [PubMed] [Google Scholar]
  84. Manning A. P., Heaton K. W., Harvey R. F. Wheat fibre and irritable bowel syndrome. A controlled trial. Lancet. 1977 Aug 27;2(8035):417–418. doi: 10.1016/s0140-6736(77)90605-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  85. Manning A. P., Thompson W. G., Heaton K. W., Morris A. F. Towards positive diagnosis of the irritable bowel. Br Med J. 1978 Sep 2;2(6138):653–654. doi: 10.1136/bmj.2.6138.653. [DOI] [PMC free article] [PubMed] [Google Scholar]
  86. Martínez V., Rivier J., Wang L., Taché Y. Central injection of a new corticotropin-releasing factor (CRF) antagonist, astressin, blocks CRF- and stress-related alterations of gastric and colonic motor function. J Pharmacol Exp Ther. 1997 Feb;280(2):754–760. [PubMed] [Google Scholar]
  87. Matts S. G. An assessment of dicyclomine hydrochloride ('Merbentyl') in the irritable colon syndrome. Br J Clin Pract. 1967 Nov 11;21(11):549–551. [PubMed] [Google Scholar]
  88. Maxton D. G., Morris J., Whorwell P. J. More accurate diagnosis of irritable bowel syndrome by the use of 'non-colonic' symptomatology. Gut. 1991 Jul;32(7):784–786. doi: 10.1136/gut.32.7.784. [DOI] [PMC free article] [PubMed] [Google Scholar]
  89. McKendrick M. W., Read N. W. Irritable bowel syndrome--post salmonella infection. J Infect. 1994 Jul;29(1):1–3. doi: 10.1016/s0163-4453(94)94871-2. [DOI] [PubMed] [Google Scholar]
  90. McMahon S. B. Neuronal and behavioural consequences of chemical inflammation of rat urinary bladder. Agents Actions. 1988 Dec;25(3-4):231–233. doi: 10.1007/BF01965020. [DOI] [PubMed] [Google Scholar]
  91. Merrick M. V., Eastwood M. A., Ford M. J. Is bile acid malabsorption underdiagnosed? An evaluation of accuracy of diagnosis by measurement of SeHCAT retention. Br Med J (Clin Res Ed) 1985 Mar 2;290(6469):665–668. doi: 10.1136/bmj.290.6469.665. [DOI] [PMC free article] [PubMed] [Google Scholar]
  92. Mertz H., Fullerton S., Naliboff B., Mayer E. A. Symptoms and visceral perception in severe functional and organic dyspepsia. Gut. 1998 Jun;42(6):814–822. doi: 10.1136/gut.42.6.814. [DOI] [PMC free article] [PubMed] [Google Scholar]
  93. Moriarty K. J., Dawson A. M. Functional abdominal pain: further evidence that whole gut is affected. Br Med J (Clin Res Ed) 1982 Jun 5;284(6330):1670–1672. doi: 10.1136/bmj.284.6330.1670. [DOI] [PMC free article] [PubMed] [Google Scholar]
  94. Myren J., Groth H., Larssen S. E., Larsen S. The effect of trimipramine in patients with the irritable bowel syndrome. A double-blind study. Scand J Gastroenterol. 1982 Oct;17(7):871–875. doi: 10.3109/00365528209181108. [DOI] [PubMed] [Google Scholar]
  95. Myren J., Løvland B., Larssen S. E., Larsen S. A double-blind study of the effect of trimipramine in patients with the irritable bowel syndrome. Scand J Gastroenterol. 1984 Sep;19(6):835–843. [PubMed] [Google Scholar]
  96. Naliboff B. D., Munakata J., Fullerton S., Gracely R. H., Kodner A., Harraf F., Mayer E. A. Evidence for two distinct perceptual alterations in irritable bowel syndrome. Gut. 1997 Oct;41(4):505–512. doi: 10.1136/gut.41.4.505. [DOI] [PMC free article] [PubMed] [Google Scholar]
  97. Nanda R., James R., Smith H., Dudley C. R., Jewell D. P. Food intolerance and the irritable bowel syndrome. Gut. 1989 Aug;30(8):1099–1104. doi: 10.1136/gut.30.8.1099. [DOI] [PMC free article] [PubMed] [Google Scholar]
  98. Narducci F., Snape W. J., Jr, Battle W. M., London R. L., Cohen S. Increased colonic motility during exposure to a stressful situation. Dig Dis Sci. 1985 Jan;30(1):40–44. doi: 10.1007/BF01318369. [DOI] [PubMed] [Google Scholar]
  99. Narducci F., Snape W. J., Jr, Battle W. M., London R. L., Cohen S. Increased colonic motility during exposure to a stressful situation. Dig Dis Sci. 1985 Jan;30(1):40–44. doi: 10.1007/BF01318369. [DOI] [PubMed] [Google Scholar]
  100. Nash P., Gould S. R., Bernardo D. E. Peppermint oil does not relieve the pain of irritable bowel syndrome. Br J Clin Pract. 1986 Jul;40(7):292–293. [PubMed] [Google Scholar]
  101. Neal K. R., Hebden J., Spiller R. Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of the irritable bowel syndrome: postal survey of patients. BMJ. 1997 Mar 15;314(7083):779–782. doi: 10.1136/bmj.314.7083.779. [DOI] [PMC free article] [PubMed] [Google Scholar]
  102. Olubuyide I. O., Olawuyi F., Fasanmade A. A. A study of irritable bowel syndrome diagnosed by Manning criteria in an African population. Dig Dis Sci. 1995 May;40(5):983–985. doi: 10.1007/BF02064186. [DOI] [PubMed] [Google Scholar]
  103. Page J. G., Dirnberger G. M. Treatment of the irritable bowel syndrome with Bentyl (dicyclomine hydrochloride). J Clin Gastroenterol. 1981 Jun;3(2):153–156. doi: 10.1097/00004836-198106000-00009. [DOI] [PubMed] [Google Scholar]
  104. Palmer K. R., Corbett C. L., Holdsworth C. D. Double-blind cross-over study comparing loperamide, codeine and diphenoxylate in the treatment of chronic diarrhea. Gastroenterology. 1980 Dec;79(6):1272–1275. [PubMed] [Google Scholar]
  105. Payne A., Blanchard E. B. A controlled comparison of cognitive therapy and self-help support groups in the treatment of irritable bowel syndrome. J Consult Clin Psychol. 1995 Oct;63(5):779–786. doi: 10.1037//0022-006x.63.5.779. [DOI] [PubMed] [Google Scholar]
  106. Poynard T., Naveau S., Mory B., Chaput J. C. Meta-analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome. Aliment Pharmacol Ther. 1994 Oct;8(5):499–510. doi: 10.1111/j.1365-2036.1994.tb00322.x. [DOI] [PubMed] [Google Scholar]
  107. Prior A., Whorwell P. J. Double blind study of ispaghula in irritable bowel syndrome. Gut. 1987 Nov;28(11):1510–1513. doi: 10.1136/gut.28.11.1510. [DOI] [PMC free article] [PubMed] [Google Scholar]
  108. Prior A., Whorwell P. J. Gynaecological consultation in patients with the irritable bowel syndrome. Gut. 1989 Jul;30(7):996–998. doi: 10.1136/gut.30.7.996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  109. Prior A., Wilson K., Whorwell P. J., Faragher E. B. Irritable bowel syndrome in the gynecological clinic. Survey of 798 new referrals. Dig Dis Sci. 1989 Dec;34(12):1820–1824. doi: 10.1007/BF01536698. [DOI] [PubMed] [Google Scholar]
  110. Prout B. J. The treatment of irritable bowel syndrome. Two doses of mebeverine compared. Practitioner. 1983 Oct;227(1384):1607–1608. [PubMed] [Google Scholar]
  111. Read N. W., Krejs G. J., Read M. G., Santa Ana C. A., Morawski S. G., Fordtran J. S. Chronic diarrhea of unknown origin. Gastroenterology. 1980 Feb;78(2):264–271. [PubMed] [Google Scholar]
  112. Rees W. D., Evans B. K., Rhodes J. Treating irritable bowel syndrome with peppermint oil. Br Med J. 1979 Oct 6;2(6194):835–836. doi: 10.1136/bmj.2.6194.835. [DOI] [PMC free article] [PubMed] [Google Scholar]
  113. Ritchie J. A., Truelove S. C. Comparison of various treatments for irritable bowel syndrome. Br Med J. 1980 Nov 15;281(6251):1317–1319. doi: 10.1136/bmj.281.6251.1317. [DOI] [PMC free article] [PubMed] [Google Scholar]
  114. Ritchie J. A., Truelove S. C. Treatment of irritable bowel syndrome with lorazepam, hyoscine butylbromide, and ispaghula husk. Br Med J. 1979 Feb 10;1(6160):376–378. doi: 10.1136/bmj.1.6160.376. [DOI] [PMC free article] [PubMed] [Google Scholar]
  115. Ritchie J. Pain from distension of the pelvic colon by inflating a balloon in the irritable colon syndrome. Gut. 1973 Feb;14(2):125–132. doi: 10.1136/gut.14.2.125. [DOI] [PMC free article] [PubMed] [Google Scholar]
  116. Rodríguez L. A., Ruigómez A. Increased risk of irritable bowel syndrome after bacterial gastroenteritis: cohort study. BMJ. 1999 Feb 27;318(7183):565–566. doi: 10.1136/bmj.318.7183.565. [DOI] [PMC free article] [PubMed] [Google Scholar]
  117. Rogers J., Henry M. M., Misiewicz J. J. Increased segmental activity and intraluminal pressures in the sigmoid colon of patients with the irritable bowel syndrome. Gut. 1989 May;30(5):634–641. doi: 10.1136/gut.30.5.634. [DOI] [PMC free article] [PubMed] [Google Scholar]
  118. Sandler R. S., Drossman D. A., Nathan H. P., McKee D. C. Symptom complaints and health care seeking behavior in subjects with bowel dysfunction. Gastroenterology. 1984 Aug;87(2):314–318. [PubMed] [Google Scholar]
  119. Sandler R. S., Drossman D. A., Nathan H. P., McKee D. C. Symptom complaints and health care seeking behavior in subjects with bowel dysfunction. Gastroenterology. 1984 Aug;87(2):314–318. [PubMed] [Google Scholar]
  120. Santos J., Saperas E., Nogueiras C., Mourelle M., Antolín M., Cadahia A., Malagelada J. R. Release of mast cell mediators into the jejunum by cold pain stress in humans. Gastroenterology. 1998 Apr;114(4):640–648. doi: 10.1016/s0016-5085(98)70577-3. [DOI] [PubMed] [Google Scholar]
  121. Sarna S., Latimer P., Campbell D., Waterfall W. E. Effect of stress, meal and neostigmine on rectosigmoid electrical control activity (ECA) in normals and in irritable bowel syndrome patients. Dig Dis Sci. 1982 Jul;27(7):582–591. doi: 10.1007/BF01297213. [DOI] [PubMed] [Google Scholar]
  122. Schlemper R. J., van der Werf S. D., Vandenbroucke J. P., Biemond I., Lamers C. B. Peptic ulcer, non-ulcer dyspepsia and irritable bowel syndrome in The Netherlands and Japan. Scand J Gastroenterol Suppl. 1993;200:33–41. doi: 10.3109/00365529309101573. [DOI] [PubMed] [Google Scholar]
  123. Schütze K., Brandstätter G., Dragosics B., Judmaier G., Hentschel E. Double-blind study of the effect of cisapride on constipation and abdominal discomfort as components of the irritable bowel syndrome. Aliment Pharmacol Ther. 1997 Apr;11(2):387–394. doi: 10.1046/j.1365-2036.1997.133311000.x. [DOI] [PubMed] [Google Scholar]
  124. Sciarretta G., Furno A., Morrone B., Malaguti P. Absence of histopathological changes of ileum and colon in functional chronic diarrhea associated with bile acid malabsorption, assessed by SeHCAT test: a prospective study. Am J Gastroenterol. 1994 Jul;89(7):1058–1061. [PubMed] [Google Scholar]
  125. Silverman D. H., Munakata J. A., Ennes H., Mandelkern M. A., Hoh C. K., Mayer E. A. Regional cerebral activity in normal and pathological perception of visceral pain. Gastroenterology. 1997 Jan;112(1):64–72. doi: 10.1016/s0016-5085(97)70220-8. [DOI] [PubMed] [Google Scholar]
  126. Smith R. C., Greenbaum D. S., Vancouver J. B., Henry R. C., Reinhart M. A., Greenbaum R. B., Dean H. A., Mayle J. E. Psychosocial factors are associated with health care seeking rather than diagnosis in irritable bowel syndrome. Gastroenterology. 1990 Feb;98(2):293–301. doi: 10.1016/0016-5085(90)90817-k. [DOI] [PubMed] [Google Scholar]
  127. Snape W. J., Jr, Carlson G. M., Cohen S. Colonic myoelectric activity in the irritable bowel syndrome. Gastroenterology. 1976 Mar;70(3):326–330. [PubMed] [Google Scholar]
  128. Snook J., Shepherd H. A. Bran supplementation in the treatment of irritable bowel syndrome. Aliment Pharmacol Ther. 1994 Oct;8(5):511–514. doi: 10.1111/j.1365-2036.1994.tb00323.x. [DOI] [PubMed] [Google Scholar]
  129. Soltoft J., Krag B., Gudmand-Hoyer E., Kristensen E., Wulff H. R. A double-blind trial of the effect of wheat bran on symptoms of irritable bowel syndrome. Lancet. 1976 Feb 7;1(7954):270–272. doi: 10.1016/s0140-6736(76)91402-1. [DOI] [PubMed] [Google Scholar]
  130. Stefanini G. F., Saggioro A., Alvisi V., Angelini G., Capurso L., di Lorenzo G., Dobrilla G., Dodero M., Galimberti M., Gasbarrini G. Oral cromolyn sodium in comparison with elimination diet in the irritable bowel syndrome, diarrheic type. Multicenter study of 428 patients. Scand J Gastroenterol. 1995 Jun;30(6):535–541. doi: 10.3109/00365529509089786. [DOI] [PubMed] [Google Scholar]
  131. Suarez F. L., Savaiano D. A., Levitt M. D. A comparison of symptoms after the consumption of milk or lactose-hydrolyzed milk by people with self-reported severe lactose intolerance. N Engl J Med. 1995 Jul 6;333(1):1–4. doi: 10.1056/NEJM199507063330101. [DOI] [PubMed] [Google Scholar]
  132. Svedlund J., Sjödin I., Dotevall G., Gillberg R. Upper gastrointestinal and mental symptoms in the irritable bowel syndrome. Scand J Gastroenterol. 1985 Jun;20(5):595–601. doi: 10.3109/00365528509089702. [DOI] [PubMed] [Google Scholar]
  133. Svedlund J., Sjödin I., Ottosson J. O., Dotevall G. Controlled study of psychotherapy in irritable bowel syndrome. Lancet. 1983 Sep 10;2(8350):589–592. doi: 10.1016/s0140-6736(83)90678-5. [DOI] [PubMed] [Google Scholar]
  134. Svendsen J. H., Munck L. K., Andersen J. R. Irritable bowel syndrome--prognosis and diagnostic safety. A 5-year follow-up study. Scand J Gastroenterol. 1985 May;20(4):415–418. doi: 10.3109/00365528509089673. [DOI] [PubMed] [Google Scholar]
  135. Symons P., Jones M. P., Kellow J. E. Symptom provocation in irritable bowel syndrome. Effects of differing doses of fructose-sorbitol. Scand J Gastroenterol. 1992 Nov;27(11):940–944. doi: 10.3109/00365529209000167. [DOI] [PubMed] [Google Scholar]
  136. Talley N. J., Boyce P. M., Jones M. Is the association between irritable bowel syndrome and abuse explained by neuroticism? A population based study. Gut. 1998 Jan;42(1):47–53. doi: 10.1136/gut.42.1.47. [DOI] [PMC free article] [PubMed] [Google Scholar]
  137. Talley N. J., Gabriel S. E., Harmsen W. S., Zinsmeister A. R., Evans R. W. Medical costs in community subjects with irritable bowel syndrome. Gastroenterology. 1995 Dec;109(6):1736–1741. doi: 10.1016/0016-5085(95)90738-6. [DOI] [PubMed] [Google Scholar]
  138. Talley N. J., O'Keefe E. A., Zinsmeister A. R., Melton L. J., 3rd Prevalence of gastrointestinal symptoms in the elderly: a population-based study. Gastroenterology. 1992 Mar;102(3):895–901. doi: 10.1016/0016-5085(92)90175-x. [DOI] [PubMed] [Google Scholar]
  139. Talley N. J., Phillips S. F., Melton L. J., Mulvihill C., Wiltgen C., Zinsmeister A. R. Diagnostic value of the Manning criteria in irritable bowel syndrome. Gut. 1990 Jan;31(1):77–81. doi: 10.1136/gut.31.1.77. [DOI] [PMC free article] [PubMed] [Google Scholar]
  140. Talley N. J., Zinsmeister A. R., Van Dyke C., Melton L. J., 3rd Epidemiology of colonic symptoms and the irritable bowel syndrome. Gastroenterology. 1991 Oct;101(4):927–934. doi: 10.1016/0016-5085(91)90717-y. [DOI] [PubMed] [Google Scholar]
  141. Tasman-Jones C. Mebeverine in patients with the irritable colon syndrome: double blind study. N Z Med J. 1973 Apr;77(491):232–235. [PubMed] [Google Scholar]
  142. Taub E., Cuevas J. L., Cook E. W., 3rd, Crowell M., Whitehead W. E. Irritable bowel syndrome defined by factor analysis. Gender and race comparisons. Dig Dis Sci. 1995 Dec;40(12):2647–2655. doi: 10.1007/BF02220455. [DOI] [PubMed] [Google Scholar]
  143. Thompson W. G. Gastrointestinal symptoms in the irritable bowel compared with peptic ulcer and inflammatory bowel disease. Gut. 1984 Oct;25(10):1089–1092. doi: 10.1136/gut.25.10.1089. [DOI] [PMC free article] [PubMed] [Google Scholar]
  144. Thompson W. G., Longstreth G. F., Drossman D. A., Heaton K. W., Irvine E. J., Müller-Lissner S. A. Functional bowel disorders and functional abdominal pain. Gut. 1999 Sep;45 (Suppl 2):II43–II47. doi: 10.1136/gut.45.2008.ii43. [DOI] [PMC free article] [PubMed] [Google Scholar]
  145. Tolliver B. A., Herrera J. L., DiPalma J. A. Evaluation of patients who meet clinical criteria for irritable bowel syndrome. Am J Gastroenterol. 1994 Feb;89(2):176–178. [PubMed] [Google Scholar]
  146. Triadafilopoulos G., Simms R. W., Goldenberg D. L. Bowel dysfunction in fibromyalgia syndrome. Dig Dis Sci. 1991 Jan;36(1):59–64. doi: 10.1007/BF01300088. [DOI] [PubMed] [Google Scholar]
  147. Trimble K. C., Farouk R., Pryde A., Douglas S., Heading R. C. Heightened visceral sensation in functional gastrointestinal disease is not site-specific. Evidence for a generalized disorder of gut sensitivity. Dig Dis Sci. 1995 Aug;40(8):1607–1613. doi: 10.1007/BF02212678. [DOI] [PubMed] [Google Scholar]
  148. Trimble K. C., Farouk R., Pryde A., Douglas S., Heading R. C. Heightened visceral sensation in functional gastrointestinal disease is not site-specific. Evidence for a generalized disorder of gut sensitivity. Dig Dis Sci. 1995 Aug;40(8):1607–1613. doi: 10.1007/BF02212678. [DOI] [PubMed] [Google Scholar]
  149. Tudor G. J. A general practice study to compare alverine citrate with mebeverine hydrochloride in the treatment of irritable bowel syndrome. Br J Clin Pract. 1986 Jul;40(7):276–278. [PubMed] [Google Scholar]
  150. Valori R. M., Kumar D., Wingate D. L. Effects of different types of stress and of "prokinetic" drugs on the control of the fasting motor complex in humans. Gastroenterology. 1986 Jun;90(6):1890–1900. doi: 10.1016/0016-5085(86)90258-1. [DOI] [PubMed] [Google Scholar]
  151. Van Outryve M., Milo R., Toussaint J., Van Eeghem P. "Prokinetic" treatment of constipation-predominant irritable bowel syndrome: a placebo-controlled study of cisapride. J Clin Gastroenterol. 1991 Feb;13(1):49–57. doi: 10.1097/00004836-199102000-00012. [DOI] [PubMed] [Google Scholar]
  152. Vassallo M., Camilleri M., Phillips S. F., Brown M. L., Chapman N. J., Thomforde G. M. Transit through the proximal colon influences stool weight in the irritable bowel syndrome. Gastroenterology. 1992 Jan;102(1):102–108. doi: 10.1016/0016-5085(92)91789-7. [DOI] [PubMed] [Google Scholar]
  153. Voirol M. W., Hipolito J. Relaxation anthropoanalytique dans les syndromes de l'intestin irritable: résultats à 40 mois. Schweiz Med Wochenschr. 1987 Jul 18;117(29):1117–1119. [PubMed] [Google Scholar]
  154. Welgan P., Meshkinpour H., Beeler M. Effect of anger on colon motor and myoelectric activity in irritable bowel syndrome. Gastroenterology. 1988 May;94(5 Pt 1):1150–1156. doi: 10.1016/0016-5085(88)90006-6. [DOI] [PubMed] [Google Scholar]
  155. Welgan P., Meshkinpour H., Hoehler F. The effect of stress on colon motor and electrical activity in irritable bowel syndrome. Psychosom Med. 1985 Mar-Apr;47(2):139–149. doi: 10.1097/00006842-198503000-00005. [DOI] [PubMed] [Google Scholar]
  156. Wells N. E., Hahn B. A., Whorwell P. J. Clinical economics review: irritable bowel syndrome. Aliment Pharmacol Ther. 1997 Dec;11(6):1019–1030. doi: 10.1046/j.1365-2036.1997.00262.x. [DOI] [PubMed] [Google Scholar]
  157. Whitehead W. E., Bosmajian L., Zonderman A. B., Costa P. T., Jr, Schuster M. M. Symptoms of psychologic distress associated with irritable bowel syndrome. Comparison of community and medical clinic samples. Gastroenterology. 1988 Sep;95(3):709–714. doi: 10.1016/s0016-5085(88)80018-0. [DOI] [PubMed] [Google Scholar]
  158. Whitehead W. E., Cheskin L. J., Heller B. R., Robinson J. C., Crowell M. D., Benjamin C., Schuster M. M. Evidence for exacerbation of irritable bowel syndrome during menses. Gastroenterology. 1990 Jun;98(6):1485–1489. doi: 10.1016/0016-5085(90)91079-l. [DOI] [PubMed] [Google Scholar]
  159. Whitehead W. E., Engel B. T., Schuster M. M. Irritable bowel syndrome: physiological and psychological differences between diarrhea-predominant and constipation-predominant patients. Dig Dis Sci. 1980 Jun;25(6):404–413. doi: 10.1007/BF01395503. [DOI] [PubMed] [Google Scholar]
  160. Whitehead W. E., Holtkotter B., Enck P., Hoelzl R., Holmes K. D., Anthony J., Shabsin H. S., Schuster M. M. Tolerance for rectosigmoid distention in irritable bowel syndrome. Gastroenterology. 1990 May;98(5 Pt 1):1187–1192. doi: 10.1016/0016-5085(90)90332-u. [DOI] [PubMed] [Google Scholar]
  161. Whitehead W. E., Winget C., Fedoravicius A. S., Wooley S., Blackwell B. Learned illness behavior in patients with irritable bowel syndrome and peptic ulcer. Dig Dis Sci. 1982 Mar;27(3):202–208. doi: 10.1007/BF01296915. [DOI] [PubMed] [Google Scholar]
  162. Whorwell P. J., McCallum M., Creed F. H., Roberts C. T. Non-colonic features of irritable bowel syndrome. Gut. 1986 Jan;27(1):37–40. doi: 10.1136/gut.27.1.37. [DOI] [PMC free article] [PubMed] [Google Scholar]
  163. Whorwell P. J., Prior A., Colgan S. M. Hypnotherapy in severe irritable bowel syndrome: further experience. Gut. 1987 Apr;28(4):423–425. doi: 10.1136/gut.28.4.423. [DOI] [PMC free article] [PubMed] [Google Scholar]
  164. Whorwell P. J., Prior A., Faragher E. B. Controlled trial of hypnotherapy in the treatment of severe refractory irritable-bowel syndrome. Lancet. 1984 Dec 1;2(8414):1232–1234. doi: 10.1016/s0140-6736(84)92793-4. [DOI] [PubMed] [Google Scholar]
  165. Williams A. J., Merrick M. V., Eastwood M. A. Idiopathic bile acid malabsorption--a review of clinical presentation, diagnosis, and response to treatment. Gut. 1991 Sep;32(9):1004–1006. doi: 10.1136/gut.32.9.1004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  166. Williams C. L., Peterson J. M., Villar R. G., Burks T. F. Corticotropin-releasing factor directly mediates colonic responses to stress. Am J Physiol. 1987 Oct;253(4 Pt 1):G582–G586. doi: 10.1152/ajpgi.1987.253.4.G582. [DOI] [PubMed] [Google Scholar]
  167. Williams C. L., Villar R. G., Peterson J. M., Burks T. F. Stress-induced changes in intestinal transit in the rat: a model for irritable bowel syndrome. Gastroenterology. 1988 Mar;94(3):611–621. doi: 10.1016/0016-5085(88)90231-4. [DOI] [PubMed] [Google Scholar]
  168. Zuckerman M. J., Guerra L. G., Drossman D. A., Foland J. A., Gregory G. G. Comparison of bowel patterns in Hispanics and non-Hispanic whites. Dig Dis Sci. 1995 Aug;40(8):1763–1769. doi: 10.1007/BF02212699. [DOI] [PubMed] [Google Scholar]
  169. Zuckerman M. J., Guerra L. G., Drossman D. A., Foland J. A., Gregory G. G. Health-care-seeking behaviors related to bowel complaints. Hispanics versus non-Hispanic whites. Dig Dis Sci. 1996 Jan;41(1):77–82. doi: 10.1007/BF02208587. [DOI] [PubMed] [Google Scholar]
  170. van Tilburg A. J., de Rooij F. W., van Blankenstein M., van den Berg J. W., Bosman-Jacobs E. P. Na+-dependent bile acid transport in the ileum: the balance between diarrhea and constipation. Gastroenterology. 1990 Jan;98(1):25–32. doi: 10.1016/0016-5085(90)91286-f. [DOI] [PubMed] [Google Scholar]
  171. van der Horst H. E., van Dulmen A. M., Schellevis F. G., van Eijk J. T., Fennis J. F., Bleijenberg G. Do patients with irritable bowel syndrome in primary care really differ from outpatients with irritable bowel syndrome? Gut. 1997 Nov;41(5):669–674. doi: 10.1136/gut.41.5.669. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

[Correction]
gut_47_suppl-2_ii1__index.html (1KB, html)

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES